Acetylcholinesterase inhibition and insulin resistance in late onset Alzheimer's disease.

about

Effect of galantamine on platelet functions in healthy elderly people DPP4 Inhibitors Can Be a Drug of Choice for Type 3 Diabetes: A Mini Review.aChE and BuChE inhibition by rivastigmin have no effect on peripheral insulin resistance in elderly patients with Alzheimer disease.

P2860

Q37073166-CAD27F80-12D8-4606-90A4-24E8764D5F1E Q48178356-AA834160-88E1-457C-A6C9-018727067FE1 Q50769472-F6536CB0-96FC-4550-BC54-7C81A016682A

P2860

Acetylcholinesterase inhibition and insulin resistance in late onset Alzheimer's disease.

Item

http://www.wikidata.org/entity/Q45920578

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh-hant

name

Acetylcholinesterase inhibition and insulin resistance in late onset Alzheimer's disease.

@en

Acetylcholinesterase inhibition and insulin resistance in late onset Alzheimer's disease.

@nl

type

Item

label

Acetylcholinesterase inhibition and insulin resistance in late onset Alzheimer's disease.

@en

Acetylcholinesterase inhibition and insulin resistance in late onset Alzheimer's disease.

@nl

prefLabel

Acetylcholinesterase inhibition and insulin resistance in late onset Alzheimer's disease.

@en

Acetylcholinesterase inhibition and insulin resistance in late onset Alzheimer's disease.

@nl

P1476

Acetylcholinesterase inhibition and insulin resistance in late onset Alzheimer's disease.

@en

P2093

Ergun Bozoglu

http://www.w3.org/2001/XMLSchema#string

P2860

Mining literature for a comprehensive pathway analysis: a case study for retrieval of homocysteine related genes for genetic and epigenetic studies

Reactive oxygen species have a causal role in multiple forms of insulin resistance

Altered phosphofructokinase mRNA levels but unchanged isoenzyme pattern in brains from patients with Alzheimer's disease.

Limited value of the homeostasis model assessment to predict insulin resistance in older men with impaired glucose tolerance.

Does insulin dysfunction play a role in Alzheimer's disease?

The role of insulin resistance in the pathogenesis of Alzheimer's disease: implications for treatment.

The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: recent challenges and their implications for novel drug development.

The cholinergic lesion of Alzheimer's disease: pivotal factor or side show?

Glucose metabolism and insulin receptor signal transduction in Alzheimer disease.

Cholinesterase inhibitors used in the treatment of Alzheimer's disease: the relationship between pharmacological effects and clinical efficacy.

P304

1127-1133

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1017/S1041610209990664

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ahmet Turan Isik

P577

2009-07-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19631004

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

Acetylcholinesterase inhibition and insulin resistance in late onset Alzheimer's disease.

about

P2860

P2860

Acetylcholinesterase inhibition and insulin resistance in late onset Alzheimer's disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921